Close

Pfizer (PFE) and Merck (MRK) BioPharma Unit Get FDA Approval for BAVENCIO® (Avelumab), the 1st Immunotherapy Approved for Metastatic Merkel Cell Carcinoma

March 23, 2017 5:35 PM EDT Send to a Friend
EMD Serono, the biopharmaceutical business of Merck (NYSE: MRK) KGaA, Darmstadt, Germany in the US and Canada, and Pfizer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login